Cutter & Co Brokerage’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,944	Closed	-$210K	–	267
2021 Q4	$210K	Sell	4,944 -1,700	-26%	-$71.2K	0.06%	243
2021 Q3	$294K	Sell	6,644 -799	-11%	-$36.6K	0.07%	215
2021 Q2	$423K	Sell	7,443 -245	-3%	-$17.3K	0.1%	175
2021 Q1	$575K	Sell	7,688 -2,429	-24%	-$199K	0.14%	137
2020 Q4	$875K	Sell	10,117 -723	-7%	-$53.3K	0.23%	94
2020 Q3	$663K	Buy	10,840 +593	+6%	+$30.1K	0.2%	102
2020 Q2	$426K	Buy	10,247 +2,290	+29%	+$83.1K	0.14%	130
2020 Q1	$229K	Buy	7,957 +668	+9%	+$38.7K	0.09%	172
2019 Q4	$526K	Buy	7,289 +945	+15%	+$116K	0.18%	112
2019 Q3	$890K	Hold	6,344	–	–	0.29%	90
2019 Q2	$1.16M	Buy	6,344 +130	+2%	+$22.2K	0.37%	72
2019 Q1	$988K	Buy	6,214 +455	+8%	+$65.9K	0.28%	78
2018 Q4	$552K	Buy	5,759 +949	+20%	+$109K	0.21%	111
2018 Q3	$679K	Sell	4,810 -500	-9%	-$77.2K	0.23%	108
2018 Q2	$831K	Hold	5,310	–	–	0.32%	87
2018 Q1	$855K	Buy	5,310 +120	+2%	+$20.4K	0.34%	78
2017 Q4	$855K	Sell	5,190 -36	-0.7%	-$3.49K	0.35%	71
2017 Q3	$326K	Sell	5,226 -70	-1%	-$5.5K	0.13%	162
2017 Q2	$422K	Buy	5,296 +1,196	+29%	+$86.5K	0.17%	136
2017 Q1	$291K	Buy	+4,100	New	+$240K	0.12%	174